Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 94
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 87
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,382 Results (Page 96 of 120)
- Relevance
  Sort by

Kaposi Sarcoma Market by Type, by Treatment, by End-Users, and By Region

 Report
March 2024
200 Pages
Global

From

€3620EUR$4,150USD£3,153GBP

Orphan Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

Orally Disintegrating Tablet Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type

 Report
May 2023
108 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

 Drug Pipelines
September 2024
247 Pages
Global

From

€6935EUR$7,950USD£6,039GBP

Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
August 2025
185 Pages
Global

From

€3925EUR$4,500USD£3,419GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Stomach Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
August 2025
185 Pages
Global

From

€3925EUR$4,500USD£3,419GBP

Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence

 Report
February 2023
22 Pages
Global

From

€606EUR$695USD£528GBP

Gastric Cancer Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
112 Pages
Global

From

€4143EUR$4,750USD£3,609GBP

Immunotherapy Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4143EUR$4,750USD£3,609GBP

Cancer Cachexia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
115 Pages
Global

From

€4143EUR$4,750USD£3,609GBP

Targeted Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
May 2025
185 Pages
Global

From

€3925EUR$4,500USD£3,419GBP

Acute Lymphoblastic Leukemia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
October 2023
104 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Retinoblastoma Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
114 Pages
Global

From

€4143EUR$4,750USD£3,609GBP

Ischemic Optic Neuropathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
June 2025
245 Pages
Global

From

€4357EUR$4,995USD£3,795GBP

Progressive Fibrosing Interstitial Lung Disease Market Insight, Epidemiology and Market Forecast - 2032

 Report
August 2022
181 Pages
Global

From

€6542EUR$7,500USD£5,698GBP

Checkpoint Inhibitors Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

Drugs for Immunotherapy Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

TNF Alpha Inhibitors Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

Minimal Residual Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4143EUR$4,750USD£3,609GBP

Immuno-oncology Market

 Report
January 2024
200 Pages
Global

From

€3620EUR$4,150USD£3,153GBP

2,382 Results (Page 96 of 120)
- 1
- 94
- 95
- 96
- 97
- 98

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.